Feng Ming Liu
Directeur Général chez Changzhou Biowin Pharmaceutical Co., Ltd.
Postes actifs de Feng Ming Liu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Changzhou Biowin Pharmaceutical Co., Ltd.
 Changzhou Biowin Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Changzhou Biowin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and distribution of point-of-care diagnostic test kits (POCT). Its products include vitro diagnostic tools, Chinese patents and related applications for treating heart disease, infectious diseases, stroke, kidney function, diabetes, cancer, and bone metabolism disorders. The company also operates research laboratory, technology platforms, and response system for the development of emergency-use diagnostic product. Changzhou Biowin Pharmaceutical was founded on November 22, 2011 and is headquartered in Changzhou, China. | Directeur Général | 01/01/2012 | - |
| Président | 01/01/2012 | - | |
| Directeur Technique/Scientifique/R&D | 01/01/2012 | - |
Historique de carrière de Feng Ming Liu
Anciens postes connus de Feng Ming Liu
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| SHINECO, INC. | Directeur Général | 03/08/2020 | - |
| Directeur Technique/Scientifique/R&D | 03/08/2020 | - |
Formation de Feng Ming Liu
| Peking Union Medical College | Doctorate Degree |
Statistiques
Internationale
| Chine | 4 |
Opérationnelle
| Chief Executive Officer | 2 |
| Chief Tech/Sci/R&D Officer | 2 |
| Chairman | 1 |
Sectorielle
| Health Technology | 2 |
| Process Industries | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SHINECO, INC. | Process Industries |
| Entreprise privées | 1 |
|---|---|
Changzhou Biowin Pharmaceutical Co., Ltd.
Changzhou Biowin Pharmaceutical Co., Ltd. Medical SpecialtiesHealth Technology Changzhou Biowin Pharmaceutical Co., Ltd. engages in the research, development, manufacture, and distribution of point-of-care diagnostic test kits (POCT). Its products include vitro diagnostic tools, Chinese patents and related applications for treating heart disease, infectious diseases, stroke, kidney function, diabetes, cancer, and bone metabolism disorders. The company also operates research laboratory, technology platforms, and response system for the development of emergency-use diagnostic product. Changzhou Biowin Pharmaceutical was founded on November 22, 2011 and is headquartered in Changzhou, China. | Health Technology |
- Bourse
- Insiders
- Feng Ming Liu
- Expérience
